Note: Ingredients listed on restricted chemical lists
EC/CAS
233-245-9/10099-74-8
Name of the chemical
Lead dinitrate
Concentration
=1-<2,5
General Information
Version
7.6
Revision date
2025-03-12
Product name
Lead (Pb) standard solution
1.2.2. Uses advised against
For R&D use only. Not for pharmaceutical, household or other uses
Emergency telephone
+(45)-6991 8573, +(45)-8212 1212
Icons in SDS
Company Information
company name
Merck Life Science ApS
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H290, H314, H317, H351, H360D, H373, H412
Hazard statements
Code
Statements
H290
May be corrosive to metals
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Corrosive to Metals, (Category 1) H290: May be corrosive to metals. Skin corrosion, (Sub-category H314: Causes severe skin burns and eye 1B) damage. Serious eye damage, (Category H318: Causes serious eye damage. 1) Skin sensitization, (Category 1) H317: May cause an allergic skin reaction. Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Reproductive toxicity, (Category H360D: May damage the unborn child. 1A) Specific target organ toxicity - H373: May cause damage to organs repeated exposure, (Category 2), through prolonged or repeated exposure. Blood, Central nervous system, Immune system, Kidney Long-term (chronic) aquatic H412: Harmful to aquatic life with long hazard, (Category 3) lasting effects.
Signal word
Danger Danger
Hazard statements
H290 May be corrosive to metals. H314 Causes severe skin burns and eye damage. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H360D May damage the unborn child. H373 May cause damage to organs (Blood, Central nervous system, Immune system, Kidney) through prolonged or repeated exposure. H412 Harmful to aquatic life with long lasting effects. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H314 Causes severe skin burns and eye damage. H412 Harmful to aquatic life with long lasting effects. H360D May damage the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Supplemental label elements
EUH071 Corrosive to the respiratory tract. Restricted to professional users. Reduced Labeling (<= 125 ml) EUH071 Corrosive to the respiratory tract.
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.